Bone marrow engraftment and associated dermatologic sequelae in a three‐yr‐old after liver transplantation

We present a case of a three‐yr‐old child with a history of multisystem Langerhans cell histiocytosis treated with systemic chemotherapy, who developed progressive liver failure and received an orthotopic split liver transplant while continuing on chemotherapy. One month following transplant, he developed acute graft‐vs.‐host disease of the skin and gastrointestinal tract. Peripheral blood chimerism studies post‐transplant demonstrated an increasing predominance of donor lymphocytes and granulocytes. Shortly after, the patient developed vitiligo, and two yr after transplantation, the patient developed skin manifestations of psoriasis. We discuss and review the current literature, which demonstrates that chimerism following liver transplantation is rare and in our patient may be related to his profound immunosuppression around the time of liver transplant as well the development of acute graft‐versus‐host disease. While autoimmune disease can occur after solid organ and stem cell transplant, our patient developed skin manifestations of autoimmunity after liver transplantation, which is also rarely described.

[1]  J. Neuberger,et al.  Autoimmune liver disease, autoimmunity and liver transplantation. , 2014, Journal of hepatology.

[2]  B. van Hoek,et al.  Acute cellular rejection is associated with matrix metalloproteinase-2 genotype chimerism after orthotopic liver transplantation. , 2013, Transplantation proceedings.

[3]  R. Fisher,et al.  Graft-versus-host disease after solid organ transplantation: a single center experience and review of literature. , 2012, Annals of transplantation.

[4]  S. Akbulut,et al.  Graft-versus-host disease after liver transplantation: a comprehensive literature review. , 2012, World journal of gastroenterology.

[5]  S. Fan,et al.  Hematopoietic chimerism in liver transplantation patients and hematopoietic stem/progenitor cells in adult human liver , 2012, Hepatology.

[6]  T. Liang,et al.  Mesenchymal stem cells administered after liver transplantation prevent acute graft‐versus‐host disease in rats , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  P. Cochat,et al.  Et al , 2008, Archives de pediatrie : organe officiel de la Societe francaise de pediatrie.

[8]  M. Clatworthy,et al.  Vitiligo following a combined liver-kidney transplant. , 2008, Nephrology, Dialysis and Transplantation.

[9]  B. N. Akay,et al.  Vitiligo after Hematopoietic Cell Transplantation: Six Cases and Review of the Literature , 2008, Dermatology.

[10]  S. Alexander,et al.  Chimerism and tolerance in a recipient of a deceased-donor liver transplant. , 2008, The New England journal of medicine.

[11]  T. Starzl Immunosuppressive therapy and tolerance of organ allografts. , 2008, The New England journal of medicine.

[12]  M. Manns,et al.  Clinical relevance of autoantibodies after pediatric liver transplantation , 2007, Clinical transplantation.

[13]  G. Klintmalm,et al.  Acute Graft versus Host Disease After Liver Transplantation: Patterns of Lymphocyte Chimerism , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[14]  T. Starzl,et al.  Use of Alemtuzumab and Tacrolimus Monotherapy for Cadaveric Liver Transplantation: With Particular Reference to Hepatitis C Virus , 2004, Transplantation.

[15]  G. Alexander,et al.  Monitoring systemic donor lymphocyte macrochimerism to aid the diagnosis of graftversus-host disease after liver transplantation , 2004, Transplantation.

[16]  S. Fan,et al.  High frequency of chimerism in transplanted livers , 2003, Hepatology.

[17]  M. Maris,et al.  Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. , 2003, Blood.

[18]  J. Ringers,et al.  Extensive chimerism in liver transplants: Vascular endothelium, bile duct epithelium, and hepatocytes , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[19]  Y. Kwong,et al.  Graft‐versus‐host disease after liver transplantation: documentation by fluorescent in situ hybridisation and human leucocyte antigen typing , 2000, Clinical transplantation.

[20]  J. Snowden,et al.  Development of psoriasis after syngeneic bone marrow transplant from psoriatic donor: further evidence for adoptive autoimmunity , 1997, The British journal of dermatology.

[21]  H. Schlitt,et al.  PASSENGER LYMPHOCYTES IN HUMAN LIVER ALLOGRAFTS AND THEIR POTENTIAL ROLE AFTER TRANSPLANTATION , 1993, Transplantation.

[22]  R. Collins,et al.  Brief report: donor-derived long-term multilineage hematopoiesis in a liver-transplant recipient. , 1993, The New England journal of medicine.

[23]  T. Starzl,et al.  Chimerism after liver transplantation for type IV glycogen storage disease and type 1 Gaucher's disease. , 1993, The New England journal of medicine.

[24]  P. Lavin,et al.  Histiocytosis-X: Demonstration of Abnormal Immunity, T-Cell Histamine H2-Receptor Deficiency, and Successful Treatment with Thymic Extract , 1981 .